pH-responsive targeted nanoparticles release ERK-inhibitor in the hypoxic zone and sensitize free gemcitabine in mutant K-Ras-addicted pancreatic cancer cells and mouse model

Debasmita Dutta(North Dakota State University), Sushanta K. Banerjee(Kansas City VA Medical Center)
PLoS ONE
April 30, 2024
Cited by 14


Related Papers